Raised $251M in Series D funding, led by Lux Capital and Natural Capital.
The company said the funding supports increase its flight cadence, deepen its pharmaceutical partnerships, and move closer to delivering the first medicine made in space.
AfterRaise daily
21 companies raised $1.1B in disclosed rounds of $5M or more. Every figure links to its source, and every company page follows what happens next.
The company said the funding supports increase its flight cadence, deepen its pharmaceutical partnerships, and move closer to delivering the first medicine made in space.
The announcement did not set out what the funding supports.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports fully fund the advancement of its lead candidate, AC01, through Phase 2b clinical development (GOAL-HF2 trial) in patients with chronic advanced heart failure with reduced ejection fraction (HFrEF), with the goal of establishing a Phase 3-ready asset by 2028.
The company said the funding supports bring fillmore (its autonomous recruiting coworker) to general availability, expand the team from 80 to 250 people by the end of next year, open a New York office, and double down on its 10x Recruiting community and training program.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports accelerate software and AI platform capabilities, worker safety solutions, enterprise system integrations, frontline hardware, and expansion across industrial and hospitality markets.
The company said the funding supports move into more channels and markets, and fuel the expansion of its product offering.
The company said the funding supports deepen its research engine, build personalization capabilities, and grow the team across engineering, go-to-market, operations, and customer experience.
The company said the funding supports scale its platform, expand its go-to-market team, and extend its integrations to enterprise AI tools.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports expansion in the US and its entry into two new sectors: data centers and electronics manufacturing.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports advance the continued Phase 2 clinical development of AST-004, including completion of the STARFAST trial in sports-related concussion in Australian Rules Football.
The company said the funding supports accelerate platform execution, bridge the gap between market discovery and trade execution, expand the DEXTools ecosystem, and move toward its Token Generation Event (TGE).
The company said the funding supports advance the ongoing Phase 1/2 clinical trial and manufacturing activities for RTx-021 in the treatment of Stargardt disease.
The company said the funding supports build out its agent verification infrastructure, expand its team, and advance the agent-to-agent transaction verification standards.
The company said the funding supports expand operations and its business reach, as well as its development efforts.
The Daily Brief
Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.